Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
96.468,54
-0,76%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX AIM ImmunoTech Inc (AIM) AIM ImmunoTech Inc (AIM) Notizie

AIM

AIM ImmunoTech (AIM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:AIM
DataOraFonteTitoloSimboloCompagnia
20/12/202423:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:AIMAIM ImmunoTech Inc
20/12/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AIMAIM ImmunoTech Inc
17/12/202422:45GlobeNewswire Inc.AIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued Listing StandardsAMEX:AIMAIM ImmunoTech Inc
17/12/202422:41Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AIMAIM ImmunoTech Inc
17/12/202422:11Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:AIMAIM ImmunoTech Inc
17/12/202421:10Business WireAIM ImmunoTech Announces Election of Three Incumbent Board Members at Annual MeetingAMEX:AIMAIM ImmunoTech Inc
16/12/202422:59Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialAMEX:AIMAIM ImmunoTech Inc
16/12/202414:00Business WireAIM ImmunoTech Reminds Shareholders to Vote “FOR” All Four Incumbent Board Members on the WHITE Universal Proxy CardAMEX:AIMAIM ImmunoTech Inc
14/12/202422:54GlobeNewswire Inc.Kellner Group Denounces False Rumors About AIM Short Selling and Demands Immediate Accountability from Incumbent BoardAMEX:AIMAIM ImmunoTech Inc
12/12/202421:00Business WireAIM ImmunoTech Urges Shareholders to Vote on the WHITE Universal Proxy Card “FOR” All Four Incumbent Board MembersAMEX:AIMAIM ImmunoTech Inc
12/12/202415:00GlobeNewswire Inc.AIM ImmunoTech Expands Patent Portfolio with New Netherlands Composition and Methods Patent Covering Ampligen for Use in the Post-COVID Condition of FatigueAMEX:AIMAIM ImmunoTech Inc
10/12/202416:20Business WireGlass Lewis Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan, Thomas K. Equels and Dr. William M. MitchellAMEX:AIMAIM ImmunoTech Inc
06/12/202415:15GlobeNewswire Inc.AIM ImmunoTech Participates in Virtual Investor KOL Connect SegmentAMEX:AIMAIM ImmunoTech Inc
06/12/202414:34GlobeNewswire Inc.Kellner Group Urges Stockholders of AIM Immunotech to Vote the Gold CardAMEX:AIMAIM ImmunoTech Inc
05/12/202415:00Business WireISS Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan and Dr. William M. MitchellAMEX:AIMAIM ImmunoTech Inc
05/12/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AIMAIM ImmunoTech Inc
04/12/202423:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AIMAIM ImmunoTech Inc
02/12/202414:00Business WireAIM ImmunoTech Issues Presentation Detailing Why Shareholders Should NOT Elect Activist Group’s Nominees to the BoardAMEX:AIMAIM ImmunoTech Inc
27/11/202421:30Business WireAIM ImmunoTech Refutes Activist Group’s False and Misleading ClaimsAMEX:AIMAIM ImmunoTech Inc
27/11/202414:00Business WireAIM ImmunoTech Announces Cash Conservation PlanAMEX:AIMAIM ImmunoTech Inc
26/11/202413:00GlobeNewswire Inc.Kellner Group Urges Stockholders of AIM Immunotech to Vote Enclosed Gold CardAMEX:AIMAIM ImmunoTech Inc
25/11/202414:00Business WireAIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and ShareholdersAMEX:AIMAIM ImmunoTech Inc
20/11/202417:50PR Newswire (US)Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card Now for Desperately Needed Change to the AIM BoardAMEX:AIMAIM ImmunoTech Inc
19/11/202414:00GlobeNewswire Inc.AIM ImmunoTech Announces Publication of Breast Cancer Data from Roswell Park Comprehensive Cancer Center in The Journal for ImmunoTherapy of CancerAMEX:AIMAIM ImmunoTech Inc
15/11/202422:33Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:AIMAIM ImmunoTech Inc
15/11/202413:29GlobeNewswire Inc.AIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateAMEX:AIMAIM ImmunoTech Inc
14/11/202422:40Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AIMAIM ImmunoTech Inc
14/11/202421:21Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:AIMAIM ImmunoTech Inc
06/11/202415:02Edgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsAMEX:AIMAIM ImmunoTech Inc
06/11/202415:00GlobeNewswire Inc.AIM ImmunoTech to Discuss Third Quarter 2024 Financial Results on November 15, 2024 and Host Conference Call and WebcastAMEX:AIMAIM ImmunoTech Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:AIM

La tua Cronologia

AMEX
UTG
Reaves Utility Income
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network